Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02945371 · ClinicalTrials.gov registry record · NA
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
A NA study, sponsored by University of Oregon.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT02945371: Completed NA study, sponsored by University of Oregon.
NCT02945371 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02945371, a NA study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Insufficient inhibitory control is one pathway through which early adversity is related to a range of problems including excessive alcohol use, tobacco use, and unhealthy eating. The proposed research leverages a neurally informed model of inhibitory control and how it can be improved to test the efficacy of a person-centered inhibitory control intervention in a sample of mid-life individuals with early adversity. The knowledge obtained by this study could be scaled into a flexible, low-cost, and wide-ranging intervention to remediate some of the effects of early adversity on inhibitory control and thus a number of prevalent health risking behaviors.
Primary Outcome
Performance on a standard inhibitory control task (Stop-Signal) with personal risk cues
Interventions
- BEHAVIORAL Person-centered inhibitory control training
- BEHAVIORAL Active behavioral response training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT02945371 record still lists
NCT02945371 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Person-centered inhibitory control training is the first listed.
NCT02945371 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02945371 about?
NCT02945371 is a clinical study titled "Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life". Insufficient inhibitory control is one pathway through which early adversity is related to a range of problems including excessive alcohol use, tobacco use, and unhealthy eating. The proposed research leverages a neurally informed model of inhibitory control and how it can be improved to test the ef...
What is the current status of trial NCT02945371?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2014-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02945371?
The interventions under investigation include: Person-centered inhibitory control training (BEHAVIORAL), Active behavioral response training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02945371?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02945371's enrollment target sits among peer trials
103 837th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia